Blackmores: Growth to continue

Morgans
Blackmores produced an exceptional FY15 result, beating our and consensus forecasts. Management commentary, although vague in terms of details, implies growth will continue in FY16. We have made upgrades to our forecasts and valuation, but are still struggling from a fundamental view with the current share price. Hold recommendation maintained. (BKL, Hold, Price Target NZ$12.18) Report attached, here is the link to the blog site: (VIEW LINK)
1 stock mentioned

Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise

Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise